ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison
Language English Country Netherlands Media print-electronic
Document type Comparative Study, Letter
PubMed
27096965
DOI
10.1016/j.ijcard.2016.04.016
PII: S0167-5273(16)30700-8
Knihovny.cz E-resources
- Keywords
- BVS, Everolimus-eluting stent, STEMI,
- MeSH
- Survival Analysis MeSH
- Everolimus administration & dosage MeSH
- Prosthesis Implantation instrumentation MeSH
- ST Elevation Myocardial Infarction therapy MeSH
- Platelet Aggregation Inhibitors administration & dosage MeSH
- Humans MeSH
- Drug-Eluting Stents MeSH
- Propensity Score MeSH
- Tissue Scaffolds MeSH
- Absorbable Implants MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Letter MeSH
- Comparative Study MeSH
- Names of Substances
- Everolimus MeSH
- Platelet Aggregation Inhibitors MeSH
Cardiology Department Interventional Cardiology Unit Virgen de la Arrixaca Hospital Murcia Spain
Cardiovascular Clinic Institute Hospital Clinic University of Barcelona IDIBAPS Barcelona Spain
Deutsches Zentrum für Herz und Kreislauf Forschung Standort Rhein Main Mainz Germany
Institute of Cardiology Hospital of Bellvitge Barcelona Spain
References provided by Crossref.org